Showing 81-90 of 2985 results for "".
The Laser Graveyard
https://practicaldermatology.com/topics/practice-management/the-laser-graveyard/18548/If old devices are taking up space in your office, it's time to get rid of them. Consider donating them or even selling them. Buyer, beware, if you are considering buying a second-hand laser. They can be a good option for a practice looking to save money, but you may not get a warranty.Robert Grant Steps Down at Alphaeon; Skin Cancer Special Edition
https://practicaldermatology.com/topics/skin-cancer-photoprotection/dermwiretv-robert-grant-steps-down-at-alphaeon-skin-cancer-special-edition/18595/Robert Grant is no longer CEO of lifestyle healthcare company Alphaeon. Mr. Grant founded Alphaeon in 2013 as a wholly owned subsidiary of Strathspey Crown LLC, a private equity firm located in Newport Beach, CA, where he serves as Chairman. Also in this issue, a closer look at skin cancer. May is SCynosure, Cutera Laser Clearances; Surgeon General Takes on Skin Cancer
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-cynosure-cutera-laser-clearances-surgeon-general-takes-on-skin-cancer/19096/In this edition of DermWireTV, from the publishers of Practical Dermatology® and Modern Aesthetics® host Devyn Gehrit offers highlights of the annual summer meeting, explores a new skin cancer initiative by the Surgeon General, and covers FDA clearances for Cynosure and Cutera laser systems.Noah Worcester 2024: Dr. Glick on Systemic Therapies for Psoriasis
https://practicaldermatology.com/conferences/noah-worcester-2024/noah-worcester-2024-dr-glick-systemic-therapies-psoriasis/26350/Brad Glick, DO, MPH, summarizes his lecture on systemic therapies for psoriasis at the 2024 Noah Worcester Dermatological Society meeting.How Physicians Can Use the New AD Guidelines in Practice
https://practicaldermatology.com/series/practical-dermatology-journal-club-atopic-dermatitis/how-physicians-can-use-the-new-ad-guidelines-in-practice/24094/In this second part of the inaugural edition of Practical Dermatology's® Atopic Dermatitis (AD) Journal Club, Derek Chu, MD, a key architect of new guidelines for AD management and care, talks with Peter Lio, MD, about his vision for how to make these guidelines easy-to-use and practical for dermatoMore than Just Oil Factories: A New Understanding of the Function of Sebaceous Glands
https://practicaldermatology.com/columns/clinical-focus-1/more-than-just-oil-factories-a-new-understanding-of-the-function-of-sebaceous-glands/23686/The sebaceous glands function as both immune and endocrine organs.Getting The Red Out: Expert Tips
https://practicaldermatology.com/topics/practice-management/getting-the-red-out-expert-tips/20701/Dermatologists share their go-to approaches for reducing facial redness in rosacea.DermWireTV: Birch Triterpenes Gel Gets FDA Approval for EB, VTE Risk is Lower in Patients with AD, and Are Topical Steroids Affecting Bone Health?
https://practicaldermatology.com/series/dermwire-tv/dermwiretv-birch-triterpenes-t-gel-gets-fda-approval-for-eb-vte-risk-is-lower-in-patients-with-ad-and-are-topical-steroids-affecting-bone-health/20233/A birch bark extract topical from Chiesi Global Rare Diseases represents the latest in treatment approvals for epidermolysis bullosa. Patients with atopic dermatitis may have a decreased risk for developing venous thromboembolism. Commonly prescribed topical steroids may raise some patients' risk foA Growing Neuromodulator Market: Daxxify Approved
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/a-growing-neuromodualtor-market-daxxify-approved/23797/Revance Therapeutics’ DaxibotulinumtoxinA-lanm is now approved to treat glabellar lines.Global Aesthetics Trends: 5 Take-aways
https://practicaldermatology.com/topics/aesthetics-cosmeceuticals/global-aesthetics-trends-5-take-aways/23795/New data on the global aesthetics market show there’s expansion in sheer patient volume as well as in who is seeking cosmetic treatments.